Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Data on cancer vaccines described by researchers at L. Hirszfeld Institute of Immunology and Experimental Therapy
April 23rd, 2008
Investigators publish new data in the report 'Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.' "Bacteriophages in eukaryotic hosts may behave as particulate antigens able to activate the innate immune system and generate adaptive immunity. Dendritic cells (DCs) play a key role in the initiation of the immune response, mainly by priming T cell-mediated immunity," scientists in Wroclaw, Poland report. "For this reason, they are increasingly applied as an adjuvant for effective anti-tumor therapies in animal models as well as in a few clinical trials. The presented study focused on the application of...
Source: Vaccine Weekly (2008-04-23)
|
